CVS Health (CVS) is set to name David Joyner, president of CVS Caremark, as its new CEO, succeeding Karen Lynch, The Wall Street Journal’s Anna Wilde Mathews reports. He will take over as president and CEO on Friday, according to the report. Roger Farah, chairman of CVS’s board of directors, will also become executive chair. CVS is now planning to announce Q3 results that will fall short of Street expectations and to back away from its most recent guidance for 2024, issued in August. “We believe that we have a really important part to play in terms of simplifying and delivering a better healthcare experience for this country,” Joyner said. CVS’s assembled assets will allow it “to actually deliver on the promises that we’ve made, and now it’s all about execution.”
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- CVS tells Reuters it is exiting core infusions services business
- Buy/Sell: Wall Street’s top 10 stock calls this week
- CVS Health’s Aetna recommended for new D-SNP contract by state of Michigan
- Humana star shortfall largest in managed care, says Morgan Stanley
- Election 2024: Where To Put Your Money Ahead of the Vote